Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Spyre Therapeutics (SYRE) Return on Assets (2016 - 2025)

Historic Return on Assets for Spyre Therapeutics (SYRE) over the last 10 years, with Q3 2025 value amounting to 0.29%.

  • Spyre Therapeutics' Return on Assets rose 2200.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.44% for FY2024, which is 12000.0% up from last year.
  • Spyre Therapeutics' Return on Assets amounted to 0.29% in Q3 2025, which was up 2200.0% from 0.37% recorded in Q2 2025.
  • Over the past 5 years, Spyre Therapeutics' Return on Assets peaked at 0.29% during Q3 2025, and registered a low of 1.84% during Q2 2023.
  • For the 5-year period, Spyre Therapeutics' Return on Assets averaged around 0.76%, with its median value being 0.55% (2021).
  • As far as peak fluctuations go, Spyre Therapeutics' Return on Assets plummeted by -9200bps in 2023, and later skyrocketed by 14400bps in 2024.
  • Spyre Therapeutics' Return on Assets (Quarter) stood at 0.55% in 2021, then crashed by -87bps to 1.03% in 2022, then decreased by -20bps to 1.23% in 2023, then soared by 67bps to 0.4% in 2024, then grew by 29bps to 0.29% in 2025.
  • Its Return on Assets stands at 0.29% for Q3 2025, versus 0.37% for Q2 2025 and 0.35% for Q1 2025.